Launched in 2019, the inquiry sought to investigate allegations of racial profiling by medical schemes. As 2024 draws to a close, the CMS is still battling objections and technical reviews to finalise the report.
BHF-commissioned study identifies 11 assertions made about private healthcare and medical schemes that lack foundation.
The signing of the NHI Act does not mean the BHF is letting up in its fight for regulations on low-cost benefit options.
The BHF’s canvassing of key policy issues in the public domain via a ‘deliberately leaked’ lawyer’s letter indicates the organisation ‘has run out of creative ideas’.
The CMS asserts that medical schemes have frequently disregarded the existing appeals procedures, exploiting them to the detriment of members’ interests.
The regulator comes out swinging in its response to the Board of Healthcare Funders’ claims of bullying and curatorship abuse.
The Supreme Court of Appeal’s dismissal of the Council for Medical Schemes’ appeal against providing documents to the Board of Healthcare Funders on low-cost benefit options marks the latest development in the ongoing legal dispute.
The announcement by the Council for Medical Schemes (CMS) that no primary health insurance plans and low-cost benefit packages would be permitted after March 2021 was met by severe criticism from the industry. […]
The announcement by the Council for Medical Schemes (CMS) that no primary health insurance plans and low-cost benefit packages would be permitted after March 2021 was met by severe criticism from the industry. […]
Two recent articles in Business Day highlight the need for circumspection before implementing the demarcation proposals. The Board of Healthcare Funders (BHF) pointed out that the affordability of medical schemes is seriously hampered […]
